Información del artículo
Resumen
La nesidioblastosis es poco común, pero ampliamente reconocida como causa de la hipoglucemia hiperinsulinémica persistente de la infancia. En adultos, el insulinoma es la principal causa de hipoglucemia hiperinsulinémica, pero también se han identificado casos de nesidioblastosis, los cuales se denominan ‘síndrome de hipoglucemia pancreatógena no insulinoma’. Los primeros casos de nesidioblastosis del adulto que fueron descritos se asociaron con otras condiciones, como insulinoma y tumores neuroendocrinos pancreáticos y MEN-1. En este artículo se describe un caso de nesidioblastosis coexistente con insulinoma en una paciente de 20 años; se hace una revisión de la literatura; se plantea la discusión sobre su posible etiología, presentación clínica, diagnóstico, tratamiento y, finalmente, se presenta un algoritmo para su estudio.
Palabras clave:
Hipoglucemia
hiperinsulinismo
nesidioblastosis
insulinoma
adulto
Abstract
Nesidioblastosis is infrequent; however, it is widely recognized as the cause of persistent infant hyperinsulinemic hypoglycemia. Among adults, insulinoma is the major cause of hyperinsulinemia hypoglycemia, but identification has also been made of cases of nesidioblastosis which are designated as ‘non insulinoma pancreatogena hypoglycemic syndrome’. The first case descriptions of adult nesidioblastosis were associated with other conditions such as insulinoma and neuroenodocrinal pancreatic tumors, and MEN-1. This article describes a case of nesidioblastosis concurrent with insulinoma in a 20-year old patient; the literature is reviewed; discussion is provided on possible etiology, clinical manifestation, diagnosis, treatment, and a concluding algorithm.
Key words:
Hypoglycemia
hyperinsulinism
nessidioblastosis
insulinoma
adult
El Texto completo está disponible en PDF
Referencias
[1.]
G.F. Laidlaw.
Nesidioblastoma: the islet cell tumor of the pancreas.
Am J Pathol, 14 (1938), pp. 125-139
[2.]
P.U. Heitz, G. Klöppel, W.H. Häcki, J.M. Polak, A.G. Pearse.
Nesidioblastosis: the pathologic basis of persistent hyperinsulinemic hypoglycemia in infants. Morphologic and quantitative analysis of seven cases based on specific immunostaining and electron microscopy.
Diabetes, 26 (1977), pp. 632-642
[3.]
C. Sempoux, Y. Guiot, F. Jaubert, J. Rahier.
Focal and diffuse forms of congenital hyperinsulinism: the keys for differential diagnosis.
Endocr Pathol, 15 (2004), pp. 241-246
[4.]
C. Sempoux, Y. Guiot, K. Dahan, P. Moulin, M. Stevens, V. Lambot, et al.
The focal form of persistent hyperinsulinemic hypoglycemia of infancy: morphological and molecular studies show structural and functional differences with insulinoma.
Diabetes, 52 (2003), pp. 784-794
[5.]
J.C. Fournet, C. Junien.
Genetics of congenital hyperinsulinism.
Endocr Pathol, 15 (2004), pp. 233-240
[6.]
A. Reinecke-Lüthge, F. Koschoreck, G. Klöppel.
The molecular basis of persistent hyperinsulinemic hypoglycemia of infancy and its pathologic substrates.
Virchows Arch, 436 (2000), pp. 1-5
[8.]
R. Santer, M. Kinner, M. Passarge, A. Superti-Furga, E. Mayatepek, T. Meissner, et al.
Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome.
Hum Genet, 108 (2001), pp. 66-71
[9.]
G. Klöppel, M. Anlauf, A. Raffel, A. Perren, W.T. Knoefel.
Adult diffuse nesidioblastosis: genetically or environmentally induced?.
Human Pathology, 39 (2008), pp. 3-8
[10.]
A. Raffel, M. Krausch, M. Anlauf, D. Wieben, S. Braunstein, G. Klöppel, et al.
Diffuse nesidioblastosis as a cause of hyperinsulinemic hypoglycemia in adults: a diagnostic and therapeutic challenge.
Surgery, 141 (2007), pp. 179-184
[11.]
S.S. Fajans, A.I. Vinik.
Insulin-producing islet cell tumors.
Endocrinol Metab Clin North Am, 18 (1989), pp. 45-74
[12.]
B.C. Van der Wal, R.R. de Krijger, W.W. de Herder, D.J. Kwekkeboom, F. van der Ham, H.J. Bonjer, et al.
Adult hyperinsulinemic hypoglycemia not caused by an insulinoma: a report of two cases.
Virchows Arch, 436 (2000), pp. 481-486
[13.]
R. Sandler, D.L. Horwitz, A.H. Rubenstein, H. Kuzuya.
Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus Application of the C-peptide assay to diagnosis and therapy.
Am J Med, 59 (1975), pp. 730-736
[14.]
J.K. Harness, G.W. Geelhoed, N.W. Thompson, R.H. Nishiyama, S.S. Fajans, R.O. Kraft, et al.
Nesidioblastosis in adults. A surgical dilemma.
Arch Surg, 116 (1981), pp. 575-580
[15.]
M. Anlauf, D. Wieben, A. Perren, B. Sipos, P. Komminoth, A. Raffel, et al.
Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence and characterization of β-cell changes.
Am J Surg Pathol, 29 (2005), pp. 524-533
[16.]
M.E. Patti, G. McMahon, E.C. Mun, A. Bitton, J.J. Holst, J. Goldsmith, et al.
Severe hypoglycemia post gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia.
Diabetologia, 48 (2005), pp. 2236-2240
[17.]
G.J. Service, G.B. Thompson, F.J. Service, J.C. Andrews, M.L. Collazo- Clavell, R.V. Lloyd.
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
N Engl J Med, 353 (2005), pp. 249-254
[18.]
M.A. Sperling, R.K. Menon.
Hyperinsulinemic hypoglycaemia of infancy Recent insights into ATP sensitive potassium channels, sulfonylurea receptors, molecular mechanisms, and treatment.
Endocrinol Metab Clin North Am, 28 (1999), pp. 695-708
[19.]
M.J. Dunne, C. Kane, R.M. Shepherd, J.A. Sanchez, R.F. James, P.R. Johnson, et al.
Familial persistent huperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor.
N Engl J Med, 336 (1997), pp. 703-706
[20.]
S.L. Shyng, T. Ferrigni, J.B. Shepard, A. Nestorowicz, B. Glaser, M.A. Permutt, et al.
Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy.
Diabetes, 47 (1998), pp. 1145-1151
[21.]
A. Nestorowicz, N. Inagaki, T. Gonoi, K.P. Schoor, B.A. Wilson, B. Glaser, et al.
A nonsense mutation in the inward rectifier potassium channel gene Kir6. 2, is associated with familial hyperinsulinism.
Diabetes, 46 (1997), pp. 1743-1748
[22.]
A. Kukuvitis, C. Deal, L. Arbour, C. Polychronakos.
An autosomal dominant form of familial persistent hyperinsulinemic hypoglycaemia of infancy not linked to the sulfonylurea receptor locus.
J Clin Endocrinol Metab, 82 (1997), pp. 1192-1194
[23.]
P.S. Thornton, M.S. Satin-Smith, K. Herold, B. Glaser, K.C. Chiu, A. Nestorowicz, et al.
Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant.
J Pediatr, 132 (1998), pp. 9-14
[24.]
D.S. Bell, W.E. Grizzle, N.E. Dunlap.
Nesidioblastosis causing reversal of insulin-dependent diabetes and development ofhyperinsulinemic hypoglycaemia.
Diabetes Care, 18 (1995), pp. 1379-1380
[25.]
G. Rayman, M. Santo, F. Salomon, S. Almog, F.J. Paradinas, J. Pinkhas, et al.
Hyperinsulinaemic hypoglycaemia due to chlorpropamida induced nesidioblastosis.
J Clin Pathol, 37 (1984), pp. 651-654
[26.]
I.L. Campbell, L.C. Harrison, C.J. Ley, P.G. Colman, D.W. Ellis.
Nesidioblastosis and multifocal pancreatic islet cell hyperplasia in an adult Clinicopathologic features and in vitro pancreatic studies.
Am J Clin Pathol, 84 (1985), pp. 534-541
[27.]
K. Kaczirek, A. Soleiman, M. Schindl, C. Passler, C. Scheuba, G. Prager, et al.
Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism.
Eur J Clin Investigation, 33 (2003), pp. 488-492
[28.]
D.R. Farley, J.A. Van Heerden, J.L. Myers.
Adult pancreatic nesidioblastosis: Unusual presentations of a rare entity.
Arch Surg, 129 (1994), pp. 329-332
[29.]
N.W. Thompson, R.V. Lloyd, R.H. Nishiyama, A.I. Vinik, W.E. Strodel, M.D. Allo, et al.
MEN 1 pancreas: a histological and immunohistochemical study.
World J Surg, 8 (1984), pp. 561-574
[30.]
D.D. De Leon, S. Deng, R. Madani, R.S. Ahima, D.J. Drucker, D.A. Stoffers.
Role of endogenous glucagons like peptide-1 in islet regeneration after partial pancreatectomy.
Diabetes, 52 (2003), pp. 365-371
[31.]
J.F. List, J.F. Habener.
Glucagon-like peptide 1 agonists and the development and growth of pancreatic b-cells.
Am J Physiol Endocrinol Metab, 286 (2004), pp. E875-E881
[32.]
P.L. Brubaker, D.J. Drucker.
Minireview: glucagon-like polypeptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system.
Endocrinology, 145 (2004), pp. 2653-2659
[33.]
D. D’Alessio, T.P. Vahl.
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
Am J Physiol Endocrinol Metab, 286 (2004), pp. E882-E890
[34.]
L. Farilla, A. Bulotta, B. Hirshberg, S. Li Calzi, N. Khoury, H. Noushmehr, et al.
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Endocrinology, 144 (2003), pp. 5149-5158
[35.]
P.E. Cryer.
Glucose counterregulation: prevention and correction of hypoglycaemia in humans.
Am J Physiol, 264 (1993), pp. E149-E155
[36.]
A. Mitrakou, C. Ryan, T. Veneman, M. Mokan, T. Jenssen, I. Kiss, et al.
Hierarchy of glycemic theresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction.
Am J Physiol, 260 (1991), pp. E67-E74
[37.]
T. Bani Sacchi, D. Bani, G. Biliotti.
The endocrine pancreas in patients with insulinomas. An immunocytochemical and ultrastructural study of the nontumoral tissue with morphometrical evaluations.
Int J Pancreatol, 5 (1989), pp. 11-28
[38.]
W.B. Goudswaard, H.J. Houthoff, J. Koudstaal, R.P. Zwierstra.
Nesidioblastosis and endocrine hyperplasia of the pancreas: a secondary phenomenon.
Hum Pathol, 17 (1986), pp. 46-54
[40.]
X. Zhao, B.E. Stabile, J. Mo, J. Wang, S.W. French.
Nesidioblastosis coexisting with islet cell tumor and intraductal papillary mucinous hyperplasia.
Arch Pathol Lab Med, 125 (2001), pp. 1344-1347
[41.]
A.S. Leong, A.H. Slavotinek, B.A. Higgins.
Nesidioblastosis, islet cell hyperplasia, and adenomatosis in a case of metastasizing insulinoma: contribution to the genesis of the islet of Langerhans.
Diabetes Care, 3 (1980), pp. 537-542
[42.]
P.M. Pour, K. Kazakoff.
Stimulation of islet cell proliferation enhances pancreatic ductal carcinogenesis in the hamster model.
Am J Pathol, 149 (1996), pp. 1017-1025
[43.]
W. Götz, C. Schucht, J. Roth, F. Theuring, R. Herken.
Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Am J Pathol, 142 (1993), pp. 1493-1503
[44.]
R. Jaffe, Y. Hashida, E.J. Yunis.
Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy.
Lab Invest, 42 (1980), pp. 356-365
[45.]
F.J. Service, N. Natt.
The prolonged fast.
J Clin Endocrinol Metab, 85 (2000), pp. 3973-3974
[46.]
B. Hirshberg, A. Livi, D.L. Bartlett, S.K. Libutti, H.R. Alexander, J.L. Doppman, et al.
Forty-eight-hour fast: The diagnostic test for insulinoma.
J Clin Endocrinol Metab, 85 (2000), pp. 3222-3226
[47.]
F.J. Service.
Hypoglycemic disorders.
N Engl J Med, 332 (1995), pp. 1144-1152
[48.]
F.J. Service, A.J. Dale, L.R. Elveback, N.S. Jiang.
Insulinoma: clinical and diagnostic features of 60 consecutive cases.
Mayo Clin Proc, 51 (1976), pp. 417-429
[49.]
S.S. Fajans, A.I. Vinik.
Insulin-producing islet cell tumors.
Endocrinol Metab Clin North Am, 18 (1989), pp. 45-74
[50.]
T.S. Harrison, S.S. Fajans, J.C. Floyd, N.W. Thompson, D.A. Rasbach, R.J. Santen, et al.
Prevalence of diffuse pancreatic beta islet cell disease with hyperinsulinism: problems in recognition and management.
World J Surg, 8 (1984), pp. 583-589
[51.]
T. Rosch, C.J. Lightdale, J.F. Botet, G.A. Boyce, M.V. Sivak Jr., K. Yasuda, et al.
Localization of pancreatic endocrine tumors by endoscopic ultrasonography.
N Engl J Med, 326 (1992), pp. 1721-1726
[52.]
J.I. Botella Carretero, M.A. Valero Gonzalez, M. Lahera Vargas, S. Aréchaga, A. de Juan, C. Varela Da Costa, et al.
Diagnostic localization of insulinoma and prognostic value of postoperative glycemia monitoring.
Med Clin (Barc), 118 (2002), pp. 201-204
[53.]
N. Borsato, F. Chierichetti, P. Zanco, D. Rubello, C. Pasquali, S. Pedrazzoli, et al.
The role of 111 In-octreotide scintigraphy in the detection of APUD tumours: our experience in eighteen patients.
Q J Nucl Med, 39 (1995), pp. 113-115
[54.]
D. O'Shea, A.W. Rohrer-Theurs, J.A. Lynn, J.E. Jackson, S.R. Bloom.
Localization of insulinomas by selective intraarterial calcium injection.
J Clin Endocrinol Metab, 81 (1996), pp. 1623-1627
[55.]
M. Brandle, T. Pfammatter, G.A. Spinas, R. Lehmann, C. Schmid.
Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours.
Clin Endocrinol (Oxf), 55 (2001), pp. 357-362
[56.]
Y.M. Sung, Y.S. Do, M.K. Lee, S.W. Shin, W.C. Liu, S.W. Choo, et al.
Selective intra-arterial calcium stimulation with hepatic venous sampling for preoperative localization of insulinomas.
Korean J Radiol, 4 (2003), pp. 101-108
[57.]
R.M. Witteles, I.I.F.H. Straus, S.L. Sugg, M.R. Koka, E.A. Costa, E.L. Kaplan.
Adult-onset nesidioblastosis causing hypoglycemia.
Arch Surg, 136 (2001), pp. 656-663
[58.]
A.L. Jabri, C. Bayard.
Nesidioblastosis associated with hyperinsulinemic hypoglycemia in adults: review of the literature.
Eur J Intern Med, 15 (2004), pp. 407-410
[59.]
C. Kane, K.J. Lindley, P.R. Johnson, R.F. James, P.J. Milla, A. Aynsley- Green, et al.
Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.
J Clinl Invest, 100 (1997), pp. 1888-1893
[60.]
T.L. Fong, N.E. Warner, D. Kumar.
Pancreatic nesidioblastosis in adults.
Diabetes Care, 12 (1989), pp. 108-114
[62.]
B. Glaser, P. Kesavan, M. Heyman, E. Davis, A. Cuesta, A. Buchs, et al.
Familial hyperinsulinism caused by an activating glucokinase mutation.
N Engl J Med, 338 (1998), pp. 226-230
[63.]
T. Otonkoski, S. Andersson, O. Simell.
Somatostatin regulation of beta-cell function in the normal human fetuses and in neonates with persistent hyperinsulinemic hypoglycemia.
J Clin Endocrinol Metab, 76 (1993), pp. 184-188
Copyright © 2009. Instituto Nacional de Cancerología
